BIO logo

Bio-Rad Laboratories (BIO) Shareholders Equity

Annual Shareholders Equity

$6.57 B
-$2.17 B-24.85%

December 31, 2024


Summary


Performance

BIO Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBIObalance sheetmetrics:

Quarterly Shareholders Equity

$6.57 B
-$918.56 M-12.27%

December 31, 2024


Summary


Performance

BIO Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBIObalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

BIO Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-24.9%-27.4%
3 y3 years-52.0%-31.7%
5 y5 years+14.2%-31.7%

BIO Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-52.0%at low-52.0%at low
5 y5-year-52.0%+14.2%-57.1%+14.2%
alltimeall time-52.0%>+9999.0%-57.1%>+9999.0%

Bio-Rad Laboratories Shareholders Equity History

DateAnnualQuarterly
Dec 2024
$6.57 B(-24.8%)
$6.57 B(-12.3%)
Sep 2024
-
$7.49 B(+10.5%)
Jun 2024
-
$6.78 B(-25.1%)
Mar 2024
-
$9.05 B(+3.5%)
Dec 2023
$8.74 B(-9.1%)
$8.74 B(+3.9%)
Sep 2023
-
$8.42 B(-0.4%)
Jun 2023
-
$8.45 B(-13.5%)
Mar 2023
-
$9.76 B(+1.5%)
Dec 2022
$9.62 B(-29.7%)
$9.62 B(+13.7%)
Sep 2022
-
$8.45 B(-5.3%)
Jun 2022
-
$8.92 B(-12.4%)
Mar 2022
-
$10.18 B(-25.6%)
Dec 2021
$13.69 B(+38.5%)
$13.69 B(-10.7%)
Sep 2021
-
$15.33 B(+32.2%)
Jun 2021
-
$11.59 B(+9.3%)
Mar 2021
-
$10.61 B(+7.4%)
Dec 2020
$9.88 B(+71.7%)
$9.88 B(+12.0%)
Sep 2020
-
$8.83 B(+20.0%)
Jun 2020
-
$7.35 B(+16.8%)
Mar 2020
-
$6.29 B(+9.3%)
Dec 2019
$5.76 B(+43.1%)
$5.76 B(+12.2%)
Sep 2019
-
$5.13 B(-6.5%)
Jun 2019
-
$5.49 B(+12.8%)
Mar 2019
-
$4.86 B(+21.0%)
Dec 2018
$4.02 B(+37.2%)
$4.02 B(-18.0%)
Sep 2018
-
$4.90 B(+5.6%)
Jun 2018
-
$4.64 B(+3.4%)
Mar 2018
-
$4.49 B(+53.2%)
Dec 2017
$2.93 B(+13.6%)
$2.93 B(+2.9%)
Sep 2017
-
$2.85 B(+1.3%)
Jun 2017
-
$2.81 B(+3.8%)
Mar 2017
-
$2.71 B(+5.0%)
Dec 2016
$2.58 B(+3.6%)
$2.58 B(-4.6%)
Sep 2016
-
$2.70 B(+3.4%)
Jun 2016
-
$2.61 B(+2.8%)
Mar 2016
-
$2.54 B(+2.2%)
Dec 2015
$2.49 B(+14.0%)
$2.49 B(+2.5%)
Sep 2015
-
$2.43 B(+3.0%)
Jun 2015
-
$2.36 B(+7.3%)
Mar 2015
-
$2.20 B(+0.6%)
Dec 2014
$2.19 B(-0.1%)
$2.19 B(+0.4%)
Sep 2014
-
$2.18 B(-3.3%)
Jun 2014
-
$2.25 B(+0.8%)
Mar 2014
-
$2.23 B(+2.1%)
Dec 2013
$2.19 B(+8.5%)
$2.19 B(+2.9%)
Sep 2013
-
$2.12 B(+2.6%)
Jun 2013
-
$2.07 B(+2.0%)
Mar 2013
-
$2.03 B(+0.8%)
Dec 2012
$2.02 B(+15.5%)
$2.02 B(+4.1%)
Sep 2012
-
$1.93 B(+4.5%)
Jun 2012
-
$1.85 B(+0.7%)
Mar 2012
-
$1.84 B(+5.5%)
Dec 2011
$1.74 B(+13.5%)
$1.74 B(+3.0%)
Sep 2011
-
$1.69 B(-1.9%)
Jun 2011
-
$1.73 B(+7.0%)
Mar 2011
-
$1.61 B(+4.9%)
Dec 2010
$1.54 B(+22.0%)
$1.54 B(+7.9%)
Sep 2010
-
$1.42 B(+10.8%)
Jun 2010
-
$1.29 B(+0.2%)
Mar 2010
-
$1.28 B(+1.8%)
Dec 2009
$1.26 B(+21.0%)
$1.26 B(+4.2%)
Sep 2009
-
$1.21 B(+8.9%)
Jun 2009
-
$1.11 B(+8.1%)
Mar 2009
-
$1.03 B(-1.4%)
Dec 2008
$1.04 B(+7.1%)
$1.04 B(-0.9%)
Sep 2008
-
$1.05 B(-5.8%)
Jun 2008
-
$1.11 B(+3.0%)
Mar 2008
-
$1.08 B(+11.4%)
Dec 2007
$971.69 M(+18.6%)
$971.69 M(+2.7%)
Sep 2007
-
$946.34 M(+5.5%)
Jun 2007
-
$896.80 M(+4.2%)
Mar 2007
-
$860.66 M(+5.0%)
Dec 2006
$819.54 M
$819.54 M(+4.4%)
Sep 2006
-
$784.74 M(+3.8%)
DateAnnualQuarterly
Jun 2006
-
$756.11 M(+7.6%)
Mar 2006
-
$702.65 M(+6.8%)
Dec 2005
$657.97 M(+10.2%)
$657.97 M(+1.4%)
Sep 2005
-
$648.96 M(+3.2%)
Jun 2005
-
$628.64 M(+0.7%)
Mar 2005
-
$624.29 M(+4.6%)
Dec 2004
$596.89 M(+20.4%)
$596.89 M(+7.8%)
Sep 2004
-
$553.84 M(+1.7%)
Jun 2004
-
$544.52 M(+5.1%)
Mar 2004
-
$518.32 M(+4.5%)
Dec 2003
$495.81 M(+29.4%)
$495.81 M(+7.9%)
Sep 2003
-
$459.34 M(+2.4%)
Jun 2003
-
$448.59 M(+8.4%)
Mar 2003
-
$414.00 M(+8.1%)
Dec 2002
$383.09 M(+34.9%)
$383.09 M(+7.5%)
Sep 2002
-
$356.52 M(+4.6%)
Jun 2002
-
$340.91 M(+11.8%)
Mar 2002
-
$304.94 M(+7.4%)
Dec 2001
$283.88 M(+16.0%)
$283.88 M(+4.2%)
Sep 2001
-
$272.32 M(+6.2%)
Jun 2001
-
$256.33 M(+3.7%)
Mar 2001
-
$247.26 M(+1.1%)
Dec 2000
$244.62 M(+11.1%)
$244.62 M(+7.0%)
Sep 2000
-
$228.70 M(+2.9%)
Jun 2000
-
$222.34 M(+1.5%)
Mar 2000
-
$219.00 M(-0.5%)
Dec 1999
$220.10 M(+2.7%)
$220.10 M(-6.0%)
Sep 1999
-
$234.20 M(+2.4%)
Jun 1999
-
$228.80 M(+3.6%)
Mar 1999
-
$220.90 M(+3.1%)
Dec 1998
$214.30 M(+8.9%)
$214.30 M(+1.1%)
Sep 1998
-
$212.00 M(+0.8%)
Jun 1998
-
$210.30 M(+1.4%)
Mar 1998
-
$207.40 M(+5.4%)
Dec 1997
$196.70 M(+7.2%)
$196.70 M(+1.0%)
Sep 1997
-
$194.80 M(+0.2%)
Jun 1997
-
$194.40 M(+3.6%)
Mar 1997
-
$187.70 M(+2.3%)
Dec 1996
$183.50 M(+16.8%)
$183.50 M(+1.4%)
Sep 1996
-
$181.00 M(+4.0%)
Jun 1996
-
$174.10 M(+4.7%)
Mar 1996
-
$166.30 M(+5.9%)
Dec 1995
$157.10 M(+21.0%)
$157.10 M(+3.8%)
Sep 1995
-
$151.40 M(+2.9%)
Jun 1995
-
$147.10 M(+5.1%)
Mar 1995
-
$139.90 M(+7.8%)
Dec 1994
$129.80 M(+17.7%)
$129.80 M(+3.3%)
Sep 1994
-
$125.60 M(+3.6%)
Jun 1994
-
$121.20 M(+3.1%)
Mar 1994
-
$117.60 M(+6.6%)
Dec 1993
$110.30 M(+3.0%)
$110.30 M(-1.4%)
Sep 1993
-
$111.90 M(+0.7%)
Jun 1993
-
$111.10 M(+0.4%)
Mar 1993
-
$110.70 M(+3.4%)
Dec 1992
$107.10 M(+18.0%)
$107.10 M(-0.8%)
Sep 1992
-
$108.00 M(+2.5%)
Jun 1992
-
$105.40 M(+10.7%)
Mar 1992
-
$95.20 M(+4.8%)
Dec 1991
$90.80 M(+12.0%)
$90.80 M(+2.7%)
Sep 1991
-
$88.40 M(+2.9%)
Jun 1991
-
$85.90 M(+0.5%)
Mar 1991
-
$85.50 M(+5.4%)
Dec 1990
$81.10 M(+17.7%)
$81.10 M(+5.1%)
Sep 1990
-
$77.20 M(+0.8%)
Jun 1990
-
$76.60 M(+3.1%)
Mar 1990
-
$74.30 M(+7.8%)
Dec 1989
$68.90 M(+15.8%)
$68.90 M(+3.6%)
Sep 1989
-
$66.50 M(+3.3%)
Jun 1989
-
$64.40 M(+8.2%)
Dec 1988
$59.50 M(+18.8%)
$59.50 M(+18.8%)
Dec 1987
$50.10 M(+15.7%)
$50.10 M(+15.7%)
Dec 1986
$43.30 M(+44.8%)
$43.30 M(+44.8%)
Dec 1985
$29.90 M(+58.2%)
$29.90 M(+58.2%)
Dec 1984
$18.90 M
$18.90 M

FAQ

  • What is Bio-Rad Laboratories annual stockholders equity?
  • What is the all time high annual shareholders equity for Bio-Rad Laboratories?
  • What is Bio-Rad Laboratories annual shareholders equity year-on-year change?
  • What is Bio-Rad Laboratories quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Bio-Rad Laboratories?
  • What is Bio-Rad Laboratories quarterly shareholders equity year-on-year change?

What is Bio-Rad Laboratories annual stockholders equity?

The current annual shareholders equity of BIO is $6.57 B

What is the all time high annual shareholders equity for Bio-Rad Laboratories?

Bio-Rad Laboratories all-time high annual stockholders equity is $13.69 B

What is Bio-Rad Laboratories annual shareholders equity year-on-year change?

Over the past year, BIO annual stockholders equity has changed by -$2.17 B (-24.85%)

What is Bio-Rad Laboratories quarterly stockholders equity?

The current quarterly shareholders equity of BIO is $6.57 B

What is the all time high quarterly shareholders equity for Bio-Rad Laboratories?

Bio-Rad Laboratories all-time high quarterly stockholders equity is $15.33 B

What is Bio-Rad Laboratories quarterly shareholders equity year-on-year change?

Over the past year, BIO quarterly stockholders equity has changed by -$2.48 B (-27.42%)